Working Life: Philippe Bastide, Head of Biosimilars, Mundipharma
November 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Mundipharma, Philippe Bastide, biosimilars, leukaemia
“Don’t conform to what people want – take risks. The people who make a big difference are the ones who …
FDA commissioner Scott Gottlieb says that more rigorous approval process would be unique to opioids
November 12, 2018Sales and Marketing FDA, Gottlieb, opioid crisis, opioids
Food and Drug Administration (FDA) commissioner Scott Gottlieb has said that if a more rigorous approval process is introduced for …
AZ’s Farxiga shows strength in largest ever SGLT2 inhibitor cardiovascular outcomes study
November 12, 2018Research and Development, Sales and Marketing AstraZeneca, cardiovascular, farxiga, pharma
AstraZeneca has revealed new data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin) at the American Heart Association (AHA) …
No-deal Brexit preparations are a waste of time and money, according to Welsh industry representatives
November 12, 2018Sales and Marketing ABPI, brexit, no-deal, pharma, stockpiling
The UK government’s request that pharmaceutical companies stockpile an additional six weeks’ worth of medicine, in preparation for a no-deal …
Hundreds die in worst Ebola outbreak in Congo’s history
November 12, 2018Sales and Marketing
Hundreds have died in a recent outbreak of Ebola in the Democratic Republic of Congo (DRC), in what has been …
GSK veteran Dave Tudor joins MMIC in Scotland
November 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Scotland, dave tudor, life sciences, manufacturing
GlaxoSmithKline veteran, Dave Tudor, is set to take on the role of Managing Director of the Medicines Manufacturing Innovation Centre …
Eisai’s Lenvima wins over NICE in liver cancer in just three months
November 9, 2018Medical Communications, Sales and Marketing Cancer, Eisai, Lenvima, Levantinib, NHS, NICE, UK, liver cancer, pharma
Eisai has revealed that its multireceptor Tyrosine Kinase Inhibitor Lenvima (lenvatinib) has been recommended by NICE, meaning it can now …
Top Ten most popular articles on Pharmafile.com this week!
November 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Celgene, GSK, Novo Nordisk, politics, popular, top 10, vaccines
The biggest news this week came from Israeli biotech Zion Medical after it was announced that HIV drug Gammora was …
NICE fail to recommend AstraZeneca’s cancer drug Olaparib on cost effectiveness basis
November 9, 2018Medical Communications, Sales and Marketing AstraZeneca, NHS, NICE, UK, olaparib, pharma
Britain’s cost effectiveness body the National Institute of Health and Care Excellence (NICE) has chosen not to recommend AstraZeneca’s Olaparib …
NHS diabetes prescriptions top £1 billion a year
November 9, 2018Medical Communications, Sales and Marketing Health Education England, NHS, UK, diabetes, pharma
The NHS in England is now spending over £1billion a year on diabetes prescriptions, almost doubling in the last decade, …
Alabama’s biggest insurer will no longer cover OxyContin prescriptions
November 9, 2018Medical Communications Alabama, Blue Cross and Blue Shield, OxyContin, insurance, opioids
The state of Alabama’s biggest insurer Blue Cross and Blue Shield will no long cover opioid painkiller OxyContin. The decision …
Living with fibular hemimelia
November 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cambridge rare disease network, diagnosis, fibular hemimelia, rare disease, therapy
Helena Baker, Vice President of Clinical Strategy at Medical Research Network and a trustee of the newly formed Rare Disease …
Jazz Pharma’s Vyxeos secures NICE recommendation in acute myeloid leukaemia
November 8, 2018Sales and Marketing Cancer, NHS, NICE, UK, Vyxeos, acute myeloid leukaemia, jazz pharmaceuticals, pharma
Jazz Pharmaceuticals has revealed that NICE has chosen to recommend that its 44mg/100mg powder formulation of Vyxeos for concentrate for …
AbbVie sue NHS over hepatitis C drug procurement
November 8, 2018Business Services AbbVie, NHS, britain, court, hep C, hepatitis, ruling
American pharma firm AbbVie are suing Britain’s NHS after claiming that the health service’s procurement of hepatitis C drugs breached …
Investigational antibiotic shows high cure rates in gonorrhoea at Phase 2
November 8, 2018Research and Development National Institute of Allergy and Infectious Diseases, National Institutes of Health, gonorrhoea, pharma, zoliflodacin
A Phase 2 study sponsored by The National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National …
Pharma stocks soar after US midterm elections
November 8, 2018Business Services, Manufacturing and Production Shares, Stock, Trump, biotech, pharma, stock market
Despite the threat of a bipartisan pricing plan, pharma stocks have soared after the announcement of the results of the …
AMR superbugs expected to kill 90,000 Britons in the next 30 years
November 8, 2018Research and Development AMR, antimicrobial resistance, infectious diseases, spanish flu
Antibiotic resistant superbugs will kill more than 90,000 British people over the next thirty years if action is not taken …
Bicycle Therapeutics picks up former Pfizer head as new SVP of Pre-Clinical Development
November 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The Cambridge based biotechnology firm Bicycle therapeutics, has announced former Pfizer head Dr Phil Jeffrey as the company’s new Senior …
NICE appoints experienced pharma consultant as Director of NICE Scientific Advice
November 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, government, national institute of health and care excellence, politics, sciences
The National Institute for Health and Care Excellence (NICE) has appointed Jeanette Kusel as Director of NICE Scientific Advice. The …
Prostate cancer researchers win $2m to explore carboplatin therapy
November 7, 2018Research and Development Cancer, carboplatin therapy, prostate cancer
The US Department of Defence has awarded a coalition of researchers – made up of the Prostate Cancer Clinical Research …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
